Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Laurus Labs Limited Call Transcript 2019

Apr 30, 2019

62639_rns_2019-04-30_68b92b11-1c7a-42a5-971e-8d5a55725929.pdf

Call Transcript

Open in viewer

Opens in your device viewer

==> picture [114 x 37] intentionally omitted <==

LAURUS LABS LIMITED

LAURUS LABS LTD. Q4 & FY19 RESULTS CONFERENCE CALL ON FRIDAY, MAY 03, 2019 AT 3:00 PM IST

Laurus Labs Ltd. (Laurus), a leading research and development driven pharmaceutical company in India, will organize a conference call for Investors and Analysts, on Friday, May 03, 2019 at 3:00 pm IST.

The conference call will be initiated with a brief management discussion on the Q4 & FY19 results which will be declared on May 2, 2019. This will be followed by an interactive Question & Answer session. The call will be hosted by Kotak Institutional Equities.

Details of the conference call are as follows:

Timing 3:00pm IST on Friday, May3, 2019
Conference dial-in
Primary number +91 22 6280 1214
+91 22 7115 8115
SecondaryNumber +91 7045671221_Available all over India_
Singapore Toll Free 8001012045
HongKongToll Free 800964448
USA Toll Free 18667462133
UK Toll Free 08081011573

- ENDS –

APRIL 30, 2019

PAGE 2

==> picture [113 x 36] intentionally omitted <==

About Laurus Labs Ltd.

Laurus Labs is a leading research and development driven pharmaceutical company in India. The Company has grown consistently to become one of the leading manufacturers of Active Pharmaceutical Ingredients (APIs) for anti-retroviral (ARV) and Hepatitis C. Laurus also manufactures APIs in Oncology and other therapeutic areas. Its strategic and early investments in R&D and manufacturing infrastructure have enabled it to become one of the leading suppliers of APIs in the ARV therapeutic area. Laurus Labs also forayed into Finished Dosages Forms capabilities on the back of existing strengths in APIs. The Company is also driving growth opportunities in the Synthesis and Ingredients businesses. Corporate Identification No: L24239AP2005PLC047518.

For further information please contact

Monish Shah Laurus Labs Limited

Tel: +91 40 3980 4366 Email: [email protected]

Pavan Kumar Nerella Laurus Labs Limited Tel: +91 40 3980 4380 Email: [email protected]

APRIL 30, 2019